Catalyst Wire Dossier Catalyst Wire Dossier

Buloxibutid

buloxibutid · Vicore Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buloxibutid, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. [Phase 2]

See pricing